ClinicalTrials.Veeva

Menu

Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation

University of Washington logo

University of Washington

Status

Withdrawn

Conditions

Myopia

Treatments

Other: Spectacles with color neutral tint
Other: Spectacles with red-blocking tint
Other: Spectacles with holographic diffuser and color neutral tint
Other: Spectacles with holographic diffuser and red-blocking tint

Study type

Interventional

Funder types

Other

Identifiers

NCT01923675
SCH13693

Details and patient eligibility

About

  1. To determine the effect of spectacles with a red blocking filter on myopia progression in children.
  2. To determine the effect of spectacles with a holographic diffuser that spreads incident light rays over an angle of 0.5 degrees on myopia progression in children
  3. To determine the combined effects of spectacles with a red blocking filter and a diffuser that spreads incident light over an angle of 0.5 degrees on myopia progression in children.

Full description

In this clinical trial we will determine whether commercially available lens tints that are normally used for cosmetic purposes or for blocking sunlight have a beneficial effect of slowing axial eye growth in children with myopia when used alone or in conjunction with a holographic diffuser that blurs the image slightly.

The following procedures will be performed on a total of 240 children from 8 to 13 years of age:

  1. Color vision tests (Richmond Hardy-Rand-Rittler pseudoisochromatic plate test and/or the Rayleigh match test and/or the Neitz Test of Color Vision), and machine-based vision tests using the Titmus tester (color vision, binocularity, acuity, and heterophoria tests);
  2. each subject will provide a blood sample or a buccal swab for genetic analysis of the long and middle wavelength cone photopigment genes in order to determine the relationship between the cone opsins and myopia;
  3. eye measurements including axial length and corneal curvature will be performed using the Zeiss Intraocular Lens Master;
  4. cycloplegic autorefraction will be doe at the beginning of the study before participants start wearing the study spectacles, after 18 months if wearing the study spectacles, and 6 months after participants stop wearing the study spectacles.
  1. subjects will be randomly assigned to one of four groups, consisting of 60 subjects each, each group will be assigned one of four study spectacles.

The study spectacles for all participants will have the optimal lens corrections for both eyes.

Group 1 participants will wear spectacles with lenses tinted to blocks red light.

Group 2 participants will wear spectacles with lenses that have a holographic diffuser on surface of and that are tinted to reduce the light intensity by the same amount that the red-blocking tint does.

Group 3 participants will wear spectacles that are tinted to block red light and that have a holographic diffuser.

Group 4 participants will wear spectacles that are tinted to reduces the light intensity by the same amount that the red-blocking tint does.

Participants will wear the study glasses for 18 months. Axial length measurements will be taken twice prior to when subjects begin wearing the glasses and once every three month thereafter.

Sex

All

Ages

8 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • nearsighted having a refractive error of at least -0.5 diopters
  • myopia progression at least -.50 D per year in previous year
  • astigmatism and anisometropia not more than 1.5 D
  • distance monocular acuity 6/6 or better
  • near monocular acuity of 0.4 M or better
  • stereoacuity not more than 40 sec of arc at 40 cm
  • able to respond to subjective testing
  • no contact lens use during the study
  • able to comply with wearing the experimental lenses daily for 18 months
  • able to have axial length measurements accurately on the Zeiss Intraocular Lens Master
  • willing to donate a blood sample or a buccal swab for genetic analysis
  • can be refracted to 20/20 or 20/15

Exclusion criteria

  • glaucoma, amblyopia, strabismus
  • ocular disease
  • developmental delay
  • history of wearing bifocal lenses
  • any type of eye surgery
  • color vision deficiency

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 4 patient groups

color blocking tint
Experimental group
Description:
Spectacles with red-blocking tint subjects will wear glasses daily for 6 months and have
Treatment:
Other: Spectacles with red-blocking tint
holographic diffuser
Other group
Description:
Spectacles with color neutral tint subjects will wear glasses daily for 6 months and have
Treatment:
Other: Spectacles with holographic diffuser and color neutral tint
diffuser & color blocking tint
Other group
Description:
Spectacles with holographic diffuser and red-blocking tint subjects will wear glasses daily for 6 months and have
Treatment:
Other: Spectacles with holographic diffuser and red-blocking tint
holographic diffuser and neutral tint
Other group
Description:
Spectacles with holographic diffuser and color neutral tint subjects will wear glasses daily for 6 months and have
Treatment:
Other: Spectacles with color neutral tint

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems